INS and diabetes mellitus: Additional research has found that individuals with continuous subcutaneous insulin infusion (CSII) and CGM experience significant reductions in the occurrence of diabetes-related hospitalizations compared to individuals with CSII and the use of traditional blood glucose monitoring [23].